Stage III Bladder Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs